Efficacy and pharmacokinetics of EGFR-targeted antibody-drug conjugates following convection-enhanced delivery in mice with glioblastoma xenografts

J. Sarkaria; J. Griffith; K. Porath; J. H. Oh; K. Bakken; W. Zhang; D. Burgenske; T. Feldsien; D. Lefebvre; E. Reilly; W. Elmquist

doi:10.1016/S0959-8049(22)01042-5

Efficacy and pharmacokinetics of EGFR-targeted antibody-drug conjugates following convection-enhanced delivery in mice with glioblastoma xenografts

J. Sarkaria, J. Griffith, K. Porath, J. H. Oh, K. Bakken, W. Zhang, D. Burgenske, T. Feldsien, D. Lefebvre, E. Reilly, W. Elmquist

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S92
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)01042-5
State	Published - Oct 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(22)01042-5

Cite this

Sarkaria, J., Griffith, J., Porath, K., Oh, J. H., Bakken, K., Zhang, W., Burgenske, D., Feldsien, T., Lefebvre, D., Reilly, E., & Elmquist, W. (2022). Efficacy and pharmacokinetics of EGFR-targeted antibody-drug conjugates following convection-enhanced delivery in mice with glioblastoma xenografts. European Journal of Cancer, 174, S92. https://doi.org/10.1016/S0959-8049(22)01042-5

Sarkaria, J, Griffith, J, Porath, K, Oh, JH, Bakken, K, Zhang, W, Burgenske, D, Feldsien, T, Lefebvre, D, Reilly, E & Elmquist, W 2022, 'Efficacy and pharmacokinetics of EGFR-targeted antibody-drug conjugates following convection-enhanced delivery in mice with glioblastoma xenografts', European Journal of Cancer, vol. 174, pp. S92. https://doi.org/10.1016/S0959-8049(22)01042-5

@article{92dc32885044410bb7d988c8b9f53739,

title = "Efficacy and pharmacokinetics of EGFR-targeted antibody-drug conjugates following convection-enhanced delivery in mice with glioblastoma xenografts",

author = "J. Sarkaria and J. Griffith and K. Porath and Oh, {J. H.} and K. Bakken and W. Zhang and D. Burgenske and T. Feldsien and D. Lefebvre and E. Reilly and W. Elmquist",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)01042-5",

language = "English (US)",

volume = "174",

pages = "S92",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Efficacy and pharmacokinetics of EGFR-targeted antibody-drug conjugates following convection-enhanced delivery in mice with glioblastoma xenografts

AU - Sarkaria, J.

AU - Griffith, J.

AU - Porath, K.

AU - Oh, J. H.

AU - Bakken, K.

AU - Zhang, W.

AU - Burgenske, D.

AU - Feldsien, T.

AU - Lefebvre, D.

AU - Reilly, E.

AU - Elmquist, W.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140492755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140492755&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)01042-5

DO - 10.1016/S0959-8049(22)01042-5

M3 - Article

AN - SCOPUS:85140492755

SN - 0959-8049

VL - 174

SP - S92

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Efficacy and pharmacokinetics of EGFR-targeted antibody-drug conjugates following convection-enhanced delivery in mice with glioblastoma xenografts

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this